{"id":"zource-legacy:Sheet1:r0003029","slug":"promab-r0003029","name":"ProMab","entityKind":"company","nativeName":null,"nativeLang":null,"aliases":[],"country":"United States","countryCode":"US","region":"global","wics":[],"wicsState":"unclassified","tier":0,"tierLabel":"unreviewed","completeness":0.71,"profileStatus":"qualified","indexEligible":true,"qualificationAnchors":["official_website"],"fieldState":{"description":"provided","website":"provided","headquartersCity":"not_provided","registryAnchors":"not_provided","tier":"provided","completeness":"provided"},"href":"/api/v1/companies/promab-r0003029","web":"/en/directory/promab-r0003029","hqCity":null,"founded":null,"website":"http://www.promab.com/","ownership":null,"parent":null,"registryIds":[],"wikidataQid":null,"description":{"en":"Custom manufacturer of recombinant proteins and custom monoclonal antibodies through the integration of bioinformatics, gene cloning, protein expression and purification, and immunology. Products include cancer stem cells, cancer stem cell ","zh":"描述未提供。"},"certifications":[],"markets":[],"attributes":[{"key":"canonical_country","unit":"US","label":"United States","value":"Q14"}],"provenance":{},"sourceCoverage":[],"createdAt":null,"updatedAt":"2026-09-05T13:38:38.907Z","news":[]}